AMRX vs EIX
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported AMRX revenue for 2024-12-31 was $2.79B. Net income was -$73.9M. Revenue was up 16.7% from 2023-12-31 to 2024-12-31. AMRX currently screens at market cap $5.19B and trailing P/E 44.0.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
AMRX currently screens at market cap $5.19B and trailing P/E 44.0. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the AMRX and EIX stock pages for the full models.
Not investment advice.